J. Endrikat

J. Endrikat, H. Shapiro, Michel P Fortier, 2009, Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC.

A 1-year randomized study to evaluate the effects of a dose reduction in oral contraceptives on lipids and carbohydrate metabolism: 20 microg ethinyl estradiol combined with 100 microg levonorgestrel.

C. Gerlinger, J. Endrikat, B. Düsterberg, 2005, Contraception.

Pattern recognition in menstrual bleeding diaries by statistical cluster analysis

C. Gerlinger, J. Endrikat, G. Kallischnigg, 2009, BMC women's health.

A one-year randomized double-blind, multicentre study to evaluate the effects of an oestrogen-reduced, continuous combined hormone replacement therapy preparation containing 1 mg oestradiol valerate and 2 mg dienogest on metabolism in postmenopausal women

J. Endrikat, W. Schmidt, T. Graeser, 2007, The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception.

Safety of gadoxetate disodium: Results from the clinical phase II–III development program and postmarketing surveillance

J. Endrikat, T. Balzer, J. Breuer, 2015, Journal of magnetic resonance imaging : JMRI.

Diagnostic Efficacy and Safety of Gadoxetate Disodium vs Gadobenate Dimeglumine in Patients With Known or Suspected Focal Liver Lesions: Results of a Clinical Phase III Study

J. Endrikat, C. Zech, C. Schwenke, 2019, Magnetic resonance insights.

Safety of gadoxetate disodium: results from six clinical phase IV studies in 8194 patients

S. Y. Kim, J. Endrikat, J. Breuer, 2015, Acta radiologica.

Gadobutrol in Renally Impaired Patients

M. Gutberlet, B. Ertl-Wagner, H. Deutschmann, 2016, Investigative radiology.

Nephrogenic Systemic Fibrosis Risk After Liver Magnetic Resonance Imaging With Gadoxetate Disodium in Patients With Moderate to Severe Renal Impairment

J. Boettcher, Rajan T. Gupta, J. Endrikat, 2015, Investigative radiology.

Nephrogenic Systemic Fibrosis Risk After LiverMagnetic Resonance Imaging With Gadoxetate Disodium in Patients With Moderate to Severe Renal Impairment Results of a Prospective, Open-Label, Multicenter Study

J. Boettcher, Rajan T. Gupta, J. Endrikat, 2015 .

Impact of concentration and dilution of three macrocyclic gadolinium-based contrast agents on MRI signal intensity at 1.5T and 3T and different pulse sequences: results of a phantom study in human plasma

S. Trattnig, J. Endrikat, P. Szomolanyi, 2020, Acta Radiologica.

Comparison of the Relaxivities of Macrocyclic Gadolinium-Based Contrast Agents in Human Plasma at 1.5, 3, and 7 T, and Blood at 3 T.

S. Trattnig, J. Endrikat, P. Szomolanyi, 2019, Investigative radiology.

Post-marketing surveillance of gadobutrol for contrast-enhanced magnetic resonance imaging in Japan

K. Awai, Y. Tsushima, J. Endrikat, 2018, Japanese Journal of Radiology.

10 Years of Nephrogenic Systemic Fibrosis

J. Endrikat, T. Balzer, Sheela Agarwal, 2018, Investigative radiology.

Safety of gadobutrol: results of a non-interventional study of 3710 patients, including 404 children

J. Endrikat, G. Hahn, K. Glutig, 2018, Acta radiologica.

Safety of Gadobutrol

J. Endrikat, T. Balzer, J. Breuer, 2016, Investigative radiology.

Original research article Pituitary, ovarian and additional contraceptive effects of an estradiol-based combined oral contraceptive: results of a randomized, open-label study

J. Endrikat, C. Klipping, M. Serrani, 2013 .

Pituitary, ovarian and additional contraceptive effects of an estradiol-based combined oral contraceptive: results of a randomized, open-label study.

J. Endrikat, C. Klipping, M. Serrani, 2013, Contraception.

Is vimentin a potential prognostic factor for patients with triple-negative breast cancer?

C. Gerlinger, R. Bohle, J. Endrikat, 2020, Journal of Cancer Research and Clinical Oncology.

Axillary Ultrasound for Breast Cancer Staging: an Attempt to Identify Clinical/Histopathological Factors Impacting Diagnostic Performance

J. Endrikat, E. Solomayer, K. Ertan, 2013, Breast cancer : basic and clinical research.

Different Pearl Indices in studies of hormonal contraceptives in the United States: impact of study population.

C. Gerlinger, J. Trussell, J. Endrikat, 2014, Contraception.

Impact of CT Injector Technology and Contrast Media Viscosity on Vascular Enhancement: Evaluation in a Circulation Phantom

Michael C. McDermott, Corey A. Kemper, J. Endrikat, 2020, The British journal of radiology.

Accuracy and Repeatability of Automated Injector Versus Manual Administration of an MRI Contrast Agent—Results of a Laboratory Study

J. Endrikat, G. Jost, M. Scarpa, 2017, Investigative radiology.

A randomized study on the influence of oral contraceptives containing ethinylestradiol combined with drospirenone or desogestrel on lipid and lipoprotein metabolism over a period of 13 cycles.

C. Gerlinger, J. Endrikat, U. Gaspard, 2004, Contraception.

Safety and Efficacy of Gadoxetate Disodium–Enhanced Liver MRI in Pediatric Patients Aged >2 Months to <18 Years—Results of a Retrospective, Multicenter Study

J. Endrikat, Mercedes Martinez, J. Geller, 2016, Magnetic resonance insights.

Social and ethical issues in management accounting and control: an editorial

F. Hartmann, J. Endrikat, P. Schreck, 2017 .

A 1-year study to compare the hemostatic effects of oral contraceptive containing 20 microg of ethinylestradiol and 100 microg of levonorgestrel with 30 microg of ethinylestradiol and 100 microg of levonorgestrel.

C. Gerlinger, J. Endrikat, J. Jespersen, 2005, Contraception.

Original research article A 1-year study to compare the hemostatic effects of oral contraceptive containing 20 Ag of ethinylestradiol and 100 Ag of levonorgestrel with 30 Ag of ethinylestradiol and 100 Ag of levonorgestrel B

C. Gerlinger, J. Endrikat, J. Jespersen, 2005 .

A comparative study of the effects of the hemostatic system of two monophasic gestodene oral contraceptives containing 20 μg and 30 μg ethinylestradiol

J. Endrikat, B. Düsterberg, U. Winkler, 1996 .

Impact of oral contraceptive use on APC-resistance: a prospective, randomized clinical trial with three low-dose preparations.

C. Gerlinger, J. Endrikat, B. Düsterberg, 2001, Contraception.

An open label, comparative study of the effects of a dose-reduced oral contraceptive containing 20 microg ethinyl estradiol and 100 microg levonorgestrel on hemostatic, lipids, and carbohydrate metabolism variables.

C. Gerlinger, J. Endrikat, C. Klipping, 2002, Contraception.

Comments on the article “Tissue gadolinium deposition in hepatorenally impaired rats exposed to Gd-EOB-DTPA: evaluation with inductively coupled plasma mass spectrometry (ICP-MS)” by Tomohiro Sato, Tsutomu Tamada, Shigeru Watanabe et al. DOI 10.1007/s11547-014-0492-y

J. Endrikat, H. Pietsch, M. Sieber, 2015, La radiologia medica.

Impact of body mass index, smoking habit, alcohol consumption, physical activity and parity on disease course of women with triple-negative breast cancer

C. Gerlinger, J. Endrikat, E. Solomayer, 2019, Archives of Gynecology and Obstetrics.

A drospirenone-containing oral contraceptive improved bleeding pattern and personal satisfaction in 914 women from Jordan, Lebanon and Syria

C. Gerlinger, J. Endrikat, E. Solomayer, 2013 .

Bleeding pattern, tolerance and patient satisfaction with a drospirenone-containing oral contraceptive evaluated in 3488 women in Europe, the Middle East and Canada.

C. Gerlinger, J. Endrikat, W. Schmidt, 2009, Contraception.

A Canadian multicentre prospective study on the effects of an oral contraceptive containing 3 mg drospirenone and 30 μg ethinyl oestradiol on somatic and psychological symptoms related to water retention and on body weight

C. Gerlinger, J. Endrikat, Michel P Fortier, 2007, The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception.

Signal Intensity Increase in the Central Nervous System after Previous Gadoxetic Acid-enhanced MR Imaging.

L. Schöckel, J. Endrikat, T. Balzer, 2017, Radiology.

An empirically generated responder definition for rosacea treatment

C. Gerlinger, J. Endrikat, K. Shakery, 2017, Clinical, cosmetic and investigational dermatology.

Evaluation of menstrual bleeding patterns: a new proposal for a universal guideline based on the analysis of more than 4500 bleeding diaries

C. Gerlinger, J. Endrikat, G. Kallischnigg, 2007, The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception.

Taking stock of research on the levers of control with meta-analytic methods: Stylized facts and boundary conditions

J. Endrikat, Klaus Derfuss, Lucia Bellora-Bienengräber, 2022, Accounting, Organizations and Society.

Market Reactions to Corporate Environmental Performance Related Events: A Meta-analytic Consolidation of the Empirical Evidence

J. Endrikat, 2015, Journal of Business Ethics.

Open, multicenter comparison of efficacy, cycle control, and tolerability of a 23-day oral contraceptive regimen with 20 μg ethinyl estradiol and 75 μg gestodene and a 21-day regimen with 20 μg ethinyl estradiol and 150 μg desogestrel

C. Gerlinger, J. Endrikat, B. Düsterberg, 2001 .

Multicenter, comparative study of cycle control, efficacy and tolerability of two low-dose oral contraceptives containing 20 μg ethinylestradiol/100 μg levonorgestrel and 20 μg ethinylestradiol/500 μg norethisterone

C. Gerlinger, J. Endrikat, W. Schmidt, 2001 .

Multicenter, comparative study of cycle control, efficacy and tolerability of two low-dose oral contraceptives containing 20 microg ethinylestradiol/100 microg levonorgestrel and 20 microg ethinylestradiol/500 microg norethisterone.

C. Gerlinger, J. Endrikat, W. Schmidt, 2001, Contraception.

Open, multicenter comparison of efficacy, cycle control, and tolerability of a 23-day oral contraceptive regimen with 20 microg ethinyl estradiol and 75 microg gestodene and a 21-day regimen with 20 microg ethinyl estradiol and 150 microg desogestrel.

C. Gerlinger, J. Endrikat, B. Düsterberg, 2001, Contraception.

Comparison of efficacy, cycle control, and tolerability of two low-dose oral contraceptives in a multicenter clinical study.

C. Gerlinger, J. Endrikat, T. Strowitzki, 1999, Contraception.

A twelve-month comparative clinical investigation of two low-dose oral contraceptives containing 20 micrograms ethinylestradiol/75 micrograms gestodene and 30 micrograms ethinylestradiol/75 micrograms gestodene, with respect to efficacy, cycle control, and tolerance.

J. Endrikat, U. Müller, B. Düsterberg, 1995, Contraception.

A comparative study of the effects of the hemostatic system of two monophasic gestodene oral contraceptives containing 20 micrograms and 30 micrograms ethinylestradiol.

J. Endrikat, B. Düsterberg, U. Winkler, 1996, Contraception.

Market Reactions to Corporate Environmental Performance Related Events: A Meta-analytic Consolidation of the Empirical Evidence

J. Endrikat, 2016 .

A meta-analysis on the correlation between ovarian activity and the incidence of intermenstrual bleeding during low-dose oral contraceptive use

C. Gerlinger, J. Endrikat, B. Düsterberg, 2003, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

Ovulation inhibition with four variations of a four-phasic estradiol valerate/dienogest combined oral contraceptive: results of two prospective, randomized, open-label studies.

J. Endrikat, C. Klipping, W. Schmidt, 2008, Contraception.

A pharmacokinetic study with a low-dose oral contraceptive containing 20 μg ethinylestradiol plus 100 μg levonorgestrel

C. Gerlinger, J. Endrikat, W. Kuhnz, 2002 .

Ovulation inhibition doses of progestins: a systematic review of the available literature and of marketed preparations worldwide.

C. Gerlinger, J. Endrikat, B. Düsterberg, 2011, Contraception.

Optimal dose de-escalation trial designs for novel contraceptives in women

Christoph Gerlinger, Oke Gerke, Jan Endrikat, 2012, Comput. Stat. Data Anal..

Immunohistochemical assessment of PD-L1 expression using three different monoclonal antibodies in triple negative breast cancer patients

J. Endrikat, E. Solomayer, M. Hammadeh, 2022, Archives of Gynecology and Obstetrics.

Elevated risk for neonatal outcome following denial of pregnancy: results of a one-year prospective study compared with control groups

J. Endrikat, U. Büscher, J. Wessel, 2003, Journal of Perinatal Medicine.

Frequency of denial of pregnancy: results and epidemiological significance of a 1‐year prospective study in Berlin

J. Endrikat, J. Wessel, Ulrich Buscher, 2002, Acta obstetricia et gynecologica Scandinavica.

Cyclic menstruation-like bleeding during denied pregnancy. Is there a particular hormonal cause?

J. Endrikat, J. Wessel, 2005, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

Chromosomal abnormalities in fetuses with ultrasonographically detected neural tube defects

J. Endrikat, K. Ertan, C. Ispahi, 2011, Clinical dysmorphology.

Her2-neu score as a prognostic factor for outcome in patients with triple-negative breast cancer

T. Fehm, C. Gerlinger, R. Bohle, 2016, Journal of Cancer Research and Clinical Oncology.

Risk of Hypersensitivity Reactions to Iopromide After Intra-Arterial Versus Intravenous Administration

J. Endrikat, P. Lengsfeld, A. Michel, 2019, Investigative radiology.

Recommendation for confidence interval and sample size calculation for the Pearl Index

C. Gerlinger, J. Endrikat, B. Düsterberg, 2003, The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception.

Board Characteristics and Corporate Social Responsibility: A Meta-Analytic Investigation

Thomas W. Guenther, Edeltraud Guenther, J. Endrikat, 2020, Business & Society.

Body weight change during use of a monophasic oral contraceptive containing 20 μg ethinylestradiol and 75 μg gestodene with a comparison of the women who completed versus those who prematurely discontinued intake

C. Gerlinger, J. Endrikat, B. Düsterberg, 2001, The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception.

The levonorgestrel-releasing intrauterine system provides a reliable, long-term treatment option for women with idiopathic menorrhagia

J. Endrikat, C. Muysers, E. Solomayer, 2011, Archives of Gynecology and Obstetrics.

Estimation of menstrual blood loss volume based on menstrual diary and laboratory data

C. Gerlinger, A. Wienke, J. Endrikat, 2012, BMC Women's Health.

Muscle mass loss in patients with metastatic breast cancer

C. Gerlinger, J. Endrikat, E. Solomayer, 2019, Archives of Gynecology and Obstetrics.

Double-blind, multicenter comparison of efficacy, cycle control, and tolerability of a 23-day versus a 21-day low-dose oral contraceptive regimen containing 20 microg ethinyl estradiol and 75 microg gestodene.

C. Gerlinger, J. Endrikat, B. Düsterberg, 2001, Contraception.

Exploring the association between financial and nonfinancial carbon-related incentives and carbon performance

Christian Ott, J. Endrikat, 2022, Accounting and Business Research.

Plasma concentrations of endogenous hormones during one regular treatment cycle with a low-dose oral contraceptive and during two cycles with deliberate omission of two tablets

J. Endrikat, B. Düsterberg, P. Rosenbaum, 2004, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

Risk of Hypersensitivity Reactions to Iopromide in Children and Elderly

C. Gerlinger, J. Endrikat, P. Lengsfeld, 2021, Investigative radiology.

Review of Delphi-Based Scenario Studies: Quality and Design Considerations

Martin Nowack, Edeltraud Guenther, Jan Endrikat, 2011 .

Postnatal neuro-development of fetuses with absent end-diastolic flow in the umbilical artery and/or fetal descending aorta

J. Endrikat, H. A. Tanriverdi, A. Ertan, 2012, Archives of Gynecology and Obstetrics.

0.5 vs. 1.0 mg estradiol in combination with drospirenone for the treatment of hot flushes

C. Gerlinger, J. Endrikat, T. Schmelter, 2015, Climacteric : the journal of the International Menopause Society.

Consequences of Strategic Performance Measurement Systems: A Meta-Analytic Review

Jan Endrikat, Thomas W. Guenther, Robert Titus, 2020 .

Comparing the EQ-5D-5L utility index based on value sets of different countries: impact on the interpretation of clinical study results

C. Gerlinger, J. Endrikat, C. Schwenke, 2019, BMC Research Notes.

Environmental management control systems: a conceptualization and a review of the empirical evidence

Edeltraud Guenther, Thomas W. Guenther, Jan Endrikat, 2016 .

Gadobutrol in India—A Comprehensive Review of Safety and Efficacy

J. Endrikat, N. Anzalone, 2017, Magnetic resonance insights.

Clinical Efficacy of Reduced Dose Gadobutrol Versus Standard Dose Gadoterate for Contrast-Enhanced MRI of the CNS: An International Multicenter Prospective Crossover Trial (LEADER-75).

J. Endrikat, F. Ardellier, Y. Weon, 2021, AJR. American journal of roentgenology.

Insurance Companies’ Responses to Climate Change: Adaptation, Dynamic Capabilities and Competitive Advantage

K. Stechemesser, J. Endrikat, Nico Grasshoff, 2015, The Geneva Papers on Risk and Insurance - Issues and Practice.

Blood pressure stability in a normotensive population during intake of a monophasic oral contraceptive containing 20 μg ethinylestradiol and 75 g gestodene

C. Gerlinger, J. Endrikat, B. Düsterberg, 2001, The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception.

A profession in change: Chief financial officers’ characteristics and backgrounds in large German companies

Julia Hillmann, J. Endrikat, Max Kieslich, 2020 .

Corporate Financial Performance and Corporate Environmental Performance: A Perfect Match?

Edeltraud Guenther, Holger Hoppe, Jan Endrikat, 2012 .

Diagnostic efficacy of contrast-enhanced breast MRI versus X-ray mammography in women with different degrees of breast density

J. Barkhausen, J. Endrikat, D. Haverstock, 2020, Acta radiologica.

A Noninferiority Margin for Acne Lesion Counts

C. Gerlinger, J. Endrikat, G. Städtler, 2008 .

Efficacy and safety of two post-operative drains: results of a prospectively randomized clinical study in breast cancer patients after breast conserving surgery

C. Gerlinger, J. Endrikat, E. Solomayer, 2019, Archives of Gynecology and Obstetrics.

Blood pressure stability in a normotensive population during intake of a monophasic oral contraceptive containing 20 microg ethinylestradiol and 75 g gestodene.

C. Gerlinger, J. Endrikat, B. Düsterberg, 2001 .